Navigation Links
Medical use for waste television screens
Date:7/13/2009

Waste material from discarded televisions could be recycled and used in medicine, according to new research by scientists at the University of York.

The chemical compound polyvinyl-alcohol (PVA) is widely used in industry and is a key element of television sets with liquid crystal display (LCD) technology. When these sets are thrown away, the LCD panels are usually incinerated or buried in landfill sites.

Researchers have now found a way of recovering PVA from television screens and transforming it into a substance suitable for use in tissue scaffolds which help parts of the body regenerate. It can also be used in pills and dressings that are designed to deliver drugs to particular parts of the body.

The research is by five academics in the University's Department of Chemistry, which is home to the York Green Chemistry Centre of Excellence and the York Liquid Crystal Group, and is published in the journal Green Chemistry.

Professor James Clark, director of the York Green Chemistry Centre of Excellence and one of the author's of the research, said: "With 2.5 billion liquid crystal displays already reaching the end of their life, and LCD televisions proving hugely popular with consumers, that is a huge amount of potential waste to manage.

"It is important that we find ways of recycling as many elements of LCDs as possible so we don't simply have to resort to burying and burning them."

The researchers have developed a technique where recovered material is heated in water in a microwave and washed in ethanol to produced "expanded PVA".

One of this material's key properties is that it does not provoke a response from the human immune system, making it suitable for use in biomedicine.

The latest research is a development from a long term project, funded by the Technology Strategy Board, examining the problems posed by LCD waste in which the University of York is a partner.


'/>"/>

Contact: James Reed
jr576@york.ac.uk
44-190-443-2029
University of York
Source:Eurekalert

Page: 1

Related biology news :

1. American College of Medical Genetics responds to new FDA labeling decision for warfarin
2. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
3. Boston University biomedical engineers find chink in bacterias armor
4. $22 million gift from Alfred Taubman launches new biomedical research institute
5. USC biomedical team to participate in $6 million low vision project
6. 3 Columbia University Medical Center faculty elected to Institute of Medicine
7. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
8. UMass Medical School researchers receive $8.5M grant award to fight AIDS
9. Natural product discovery by Cleveland medical researchers blocks tissue destruction
10. Triage study challenges notions of emergency medical response to disaster
11. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: